ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
node1 |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
prov:Person |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
owl:sameAs |
https://semopenalex.org/author/A5065746624 |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEOD370935345DF7A10Multidisciplinary Sleep Disorders Centre |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
foaf:familyName |
Verbraecken |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
foaf:givenName |
Johan |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |
foaf:name |
Johan Verbraecken |
ripekg:work/10.1111%2Fjsr.14373Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by <scp>CPAP</scp>: Randomised phase 3 study |
dcterms:creator |
ripekg:author/RIPEAUAF440E44748373BCJohan Verbraecken |